254 related articles for article (PubMed ID: 26656242)
1. Procoagulant snake venoms have differential effects in animal plasmas: Implications for antivenom testing in animal models.
Maduwage KP; Scorgie FE; Lincz LF; O'Leary MA; Isbister GK
Thromb Res; 2016 Jan; 137():174-177. PubMed ID: 26656242
[TBL] [Abstract][Full Text] [Related]
2. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
[TBL] [Abstract][Full Text] [Related]
3. A turbidimetric assay for the measurement of clotting times of procoagulant venoms in plasma.
O'Leary MA; Isbister GK
J Pharmacol Toxicol Methods; 2010; 61(1):27-31. PubMed ID: 19615454
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of convergent procoagulant toxicity and differential antivenom efficacy in Australian elapid snake venoms.
Zdenek CN; den Brouw BO; Dashevsky D; Gloria A; Youngman NJ; Watson E; Green P; Hay C; Dunstan N; Allen L; Fry BG
Toxicol Lett; 2019 Nov; 316():171-182. PubMed ID: 31442586
[TBL] [Abstract][Full Text] [Related]
5. Effect of snake venom procoagulants on snake plasma: implications for the coagulation cascade of snakes.
Joseph JS; Chung MC; Mirtschin PJ; Kini RM
Toxicon; 2002 Feb; 40(2):175-83. PubMed ID: 11689239
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of ontogenetic differences in the coagulotoxic activity of Bothrops jararacussu venoms.
Rodrigues CFB; Zdenek CN; Bourke LA; Seneci L; Chowdhury A; Freitas-de-Sousa LA; de Alcantara Menezes F; Moura-da-Silva AM; Tanaka-Azevedo AM; Fry BG
Toxicol Lett; 2021 Sep; 348():59-72. PubMed ID: 34044056
[TBL] [Abstract][Full Text] [Related]
7. Pets in peril: The relative susceptibility of cats and dogs to procoagulant snake venoms.
Zdenek CN; Llinas J; Dobson J; Allen L; Dunstan N; Sousa LF; Moura da Silva AM; Fry BG
Comp Biochem Physiol C Toxicol Pharmacol; 2020 Oct; 236():108769. PubMed ID: 32376497
[TBL] [Abstract][Full Text] [Related]
8. Neutralisation of the clotting activity of Australian snake venoms by snake plasma.
Smith A; Marshall LR; Mirtschin PJ; Jelinek GA
Toxicon; 2000 Dec; 38(12):1855-8. PubMed ID: 10858522
[TBL] [Abstract][Full Text] [Related]
9. Eastern brown snake (Pseudonaja textilis) envenomation in dogs and cats: Clinical signs, coagulation changes, brown snake venom antigen levels and treatment with a novel caprylic acid fractionated bivalent whole IgG equine antivenom.
Padula AM; Leister E
Toxicon; 2017 Nov; 138():89-97. PubMed ID: 28830752
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
[TBL] [Abstract][Full Text] [Related]
11. Mud in the blood: Novel potent anticoagulant coagulotoxicity in the venoms of the Australian elapid snake genus Denisonia (mud adders) and relative antivenom efficacy.
Youngman NJ; Zdenek CN; Dobson JS; Bittenbinder MA; Gillett A; Hamilton B; Dunstan N; Allen L; Veary A; Veary E; Fry BG
Toxicol Lett; 2019 Mar; 302():1-6. PubMed ID: 30502385
[TBL] [Abstract][Full Text] [Related]
12. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies.
Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ
Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227
[TBL] [Abstract][Full Text] [Related]
13. Use of immunoturbidimetry to detect venom-antivenom binding using snake venoms.
O'Leary MA; Maduwage K; Isbister GK
J Pharmacol Toxicol Methods; 2013; 67(3):177-81. PubMed ID: 23416032
[TBL] [Abstract][Full Text] [Related]
14. Hematologic effects and complications of snake envenoming.
Berling I; Isbister GK
Transfus Med Rev; 2015 Apr; 29(2):82-9. PubMed ID: 25556574
[TBL] [Abstract][Full Text] [Related]
15. Brown snakes (Pseudonaja genus): venom yields, prothrombin activator neutralization and implications affecting antivenom usage.
Masci PP; Mirtschin PJ; Nias TN; Turnbull RK; Kuchel TR; Whitaker AN
Anaesth Intensive Care; 1998 Jun; 26(3):276-81. PubMed ID: 9619222
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic interference of Indian king cobra (Ophiophagus hannah) Venom. Comparison with three other snake venoms of the subcontinent.
Gowtham YJ; Kumar MS; Girish KS; Kemparaju K
Biochemistry (Mosc); 2012 Jun; 77(6):639-47. PubMed ID: 22817464
[TBL] [Abstract][Full Text] [Related]
17. Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom.
Zdenek CN; Hay C; Arbuckle K; Jackson TNW; Bos MHA; Op den Brouw B; Debono J; Allen L; Dunstan N; Morley T; Herrera M; Gutiérrez JM; Williams DJ; Fry BG
Toxicol In Vitro; 2019 Aug; 58():97-109. PubMed ID: 30910521
[TBL] [Abstract][Full Text] [Related]
18. Differential action of medically important Indian BIG FOUR snake venoms on rodent blood coagulation.
Hiremath V; Nanjaraj Urs AN; Joshi V; Suvilesh KN; Savitha MN; Urs Amog P; Rudresha GV; Yariswamy M; Vishwanath BS
Toxicon; 2016 Feb; 110():19-26. PubMed ID: 26592458
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and potency of antivenoms in neutralizing the procoagulant effects of Australian snake venoms in dog and human plasma.
Sprivulis P; Jelinek GA; Marshall L
Anaesth Intensive Care; 1996 Jun; 24(3):379-81. PubMed ID: 8805896
[TBL] [Abstract][Full Text] [Related]
20. Differential procoagulant effects of saw-scaled viper (Serpentes: Viperidae: Echis) snake venoms on human plasma and the narrow taxonomic ranges of antivenom efficacies.
Rogalski A; Soerensen C; Op den Brouw B; Lister C; Dashevsky D; Arbuckle K; Gloria A; Zdenek CN; Casewell NR; Gutiérrez JM; Wüster W; Ali SA; Masci P; Rowley P; Frank N; Fry BG
Toxicol Lett; 2017 Oct; 280():159-170. PubMed ID: 28847519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
